Oncopharmpod

Oncopharmpod

Lorlatinib

Informações:

Añadir a la estante
Escucha
muestra
Escucha

Sinopsis

Reviewing the latest TKI approved for ALK rearranged metastatic NSCLC. And hey, how 'bout that crazy rifampin hepatotoxicity interaction?

Show more